shuterstock-138839393

Lightspring / Shutterstock.com

27 November 2014Ranjna Mehta-Dutt and Neha Srivastava

Biologics in India: bridging the gap

Section 10(4)(ii)(D) of India’s Patents Act, 1970 mandates the disclosure of the source and geographical origin of biological material whenever it’s mentioned in a patent specification but not sufficiently described in it or made available to the public.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Diverging in the detail: UPC local divisions and Court of Appeal take different paths

Three reasons why the UK should reconsider joining the UPC

Fed Circ affirms rulings in Acadia’s fight against Parkinson’s drug copies

Ukraine law change means rightsholders need to prepare

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

Commercialising genomic tech in Nigeria

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

In vivo cell therapy: A world beyond ex vivo engineering